• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克罗恩病中髓系、淋巴系及肠道恶性肿瘤的列表

Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease.

作者信息

Freeman Hugh J

机构信息

Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, British Columbia.

出版信息

Can J Gastroenterol. 2002 Nov;16(11):779-84. doi: 10.1155/2002/193285.

DOI:10.1155/2002/193285
PMID:12464971
Abstract

A variety of malignant complications occur in Crohn's disease, and previous studies have recorded an increased intestinal cancer risk. The present investigation tabulated myeloid and lymphoid malignancies compared with intestinal cancers in 1000 consecutively evaluated patients with Crohn's disease who were followed over an extended period by a single clinician. Myeloid and lymphoid neoplasms were present in 0.5% of patients, while cancer in the intestinal tract was detected in 1%. Most of these patients with a malignancy had Crohn's disease for a prolonged period of more than 20 years and had negative outcomes, including death or presentations with advanced disease. In this cohort, lymphoma was not detected in a single patient after definition of Crohn's disease, possibly reflecting the limited use of immunosuppressives or infused biological agents in this clinical practice. Bypassed rectal 'stumps' were associated with subsequent colorectal cancer in half of all males with colon cancer in this series, suggesting an important risk factor following colectomy in Crohn's disease. Epithelial dysplasia was detected in only a single male patient before colorectal cancer, implying that this histopathological marker may be a poor predictor of subsequent colon cancer development in Crohn's disease, an inflammatory bowel disease process that is typically patchy or focal in distribution in the intestinal tract.

摘要

克罗恩病会出现多种恶性并发症,既往研究已记录其患肠癌风险增加。本研究将1000例连续接受评估的克罗恩病患者的髓系和淋巴系恶性肿瘤与肠道癌进行了列表分析,这些患者由一名临床医生进行了长期随访。髓系和淋巴系肿瘤在0.5%的患者中出现,而肠道癌在1%的患者中被检测到。这些患有恶性肿瘤的患者大多患有克罗恩病超过20年,且预后不良,包括死亡或出现晚期疾病。在这个队列中,在明确克罗恩病诊断后,没有一名患者被检测出患有淋巴瘤,这可能反映了该临床实践中免疫抑制剂或注射用生物制剂的使用有限。在本系列中,所有结肠癌男性患者中有一半的绕过直肠“残端”与随后的结直肠癌相关,这表明在克罗恩病患者行结肠切除术后这是一个重要的危险因素。在结直肠癌发生前,仅在一名男性患者中检测到上皮发育异常,这意味着这种组织病理学标志物可能不是克罗恩病患者随后结肠癌发生的良好预测指标,克罗恩病是一种炎症性肠病,其在肠道中的分布通常是散在的或局灶性的。

相似文献

1
Tabulation of myeloid, lymphoid and intestinal malignancies in Crohn's disease.克罗恩病中髓系、淋巴系及肠道恶性肿瘤的列表
Can J Gastroenterol. 2002 Nov;16(11):779-84. doi: 10.1155/2002/193285.
2
The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients.住院克罗恩病患者中淋巴和髓系恶性肿瘤的发病率。
Inflamm Bowel Dis. 2001 May;7(2):106-12. doi: 10.1097/00054725-200105000-00005.
3
Intestinal adenocarcinoma in Crohn's disease: a report of 30 cases with a focus on coexisting dysplasia.克罗恩病中的肠道腺癌:30例报告,重点关注并存的发育异常
Am J Surg Pathol. 1999 Jun;23(6):651-5. doi: 10.1097/00000478-199906000-00003.
4
Crohn's disease and adenocarcinoma of the intestinal tract. Report of four cases.克罗恩病与肠道腺癌。四例报告。
Dis Colon Rectum. 1991 Feb;34(2):174-80. doi: 10.1007/BF02049994.
5
Malignancy in Crohn's disease.
Scand J Gastroenterol. 1986 Jan;21(1):82-6. doi: 10.3109/00365528609034627.
6
Intestinal cancer in patients with Crohn's disease. A population study in central Israel.
Scand J Gastroenterol. 1989 Apr;24(3):346-50. doi: 10.3109/00365528909093058.
7
Intestinal cancer in patients with Crohn's disease.克罗恩病患者的肠道癌
Int J Colorectal Dis. 2007 Apr;22(4):411-7. doi: 10.1007/s00384-006-0164-z. Epub 2006 Jul 18.
8
Crohn's disease and cancer risk (Denmark).克罗恩病与癌症风险(丹麦)
Cancer Causes Control. 2000 Feb;11(2):145-50. doi: 10.1023/a:1008988215904.
9
[Crohn's disease and intestinal cancer].[克罗恩病与肠道癌]
Nihon Shokakibyo Gakkai Zasshi. 2006 Jul;103(7):797-804.
10
Risk of lymphoma in inflammatory bowel disease.炎症性肠病患者患淋巴瘤的风险。
Am J Gastroenterol. 2000 Sep;95(9):2308-12. doi: 10.1111/j.1572-0241.2000.02316.x.

引用本文的文献

1
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor.原发肿瘤部位的上皮-间充质转化和炎症。
Semin Cancer Biol. 2017 Dec;47:177-184. doi: 10.1016/j.semcancer.2017.08.002. Epub 2017 Aug 18.
2
Crohn's disease and smoldering multiple myeloma: a case report and literature review.克罗恩病与冒烟型多发性骨髓瘤:一例报告及文献综述
Intest Res. 2017 Apr;15(2):249-254. doi: 10.5217/ir.2017.15.2.249. Epub 2017 Apr 27.
3
Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago?
小肠腺癌与克罗恩病:相较于50年前有进展吗?
World J Gastroenterol. 2014 Sep 7;20(33):11486-95. doi: 10.3748/wjg.v20.i33.11486.
4
Mucinous carcinoma in Crohn's disease originating in a fistulous tract.克罗恩病瘘管源性黏液腺癌。
World J Gastrointest Oncol. 2010 Jul 15;2(7):307-10. doi: 10.4251/wjgo.v2.i7.307.
5
Colorectal cancer risk in Crohn's disease.克罗恩病患者患结直肠癌的风险
World J Gastroenterol. 2008 Mar 28;14(12):1810-1. doi: 10.3748/wjg.14.1810.
6
Review article: multiple myeloma and inflammatory bowel disease.
Dig Dis Sci. 2007 Sep;52(9):2022-8. doi: 10.1007/s10620-006-9165-6. Epub 2007 Apr 10.